EUVIMEDEUVIMED entdecken
Crossref

Programmed Design of Nitric Oxide and Photodynamic Therapy Based on Orthogonal Upconversion Nanoparticles Improves Anti‐Tumor Efficacy via Protein S‐nitrosylation

Chengyan Wang, Jiahui Zhu, Ling Lin, Jie Yu, Hao Xu, Jiangfeng Du, Zhanjun Gu, Xiu-Wu Bian, Jing Hu, Gan Tian, Xiao Zhang iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202502137 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Chengyan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China. Hauptthemen laut MEDLINE: Photochemotherapy, Nitric Oxide, Nanoparticles, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Southwest Hospital, Natural Science Foundation of Chongqing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effectiveness of cancer treatment has been significantly improved through combined therapies that synergistically utilize multiple treatment modalities. While combination strategy mitigates tumor resistance, enhances therapeutic efficacy, and reduces side effects compared to monotherapies, the precise coordination of treatment sequences and timing remains underexplored, particularly in the nanomaterial‐based therapies. In this study, this gap is addressed by investigating the interaction between photodynamic therapy (PDT) and nitric oxide (NO) therapy, with a specific focus on the sequence in which these therapies are administered. An upconversion nanoplatform is designed with orthogonal dual‐channel fluorescence properties, allowing for non‐interfering NO release and PDT, which enables systematic exploration of the effects of treatment sequence on therapy efficacy. The results demonstrate that administering NO therapy prior to PDT yields superior antitumor effects compared to other sequences. This time‐sequenced efficacy may be attributed to NO‐induced S‐nitrosylation, which disrupts the intracellular regeneration cycle of reduced glutathione, thereby sensitizing tumor cells to subsequent PDT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyNitric OxideNanoparticlesNeoplasmsHumansAnimalsCell Line, TumorMicePhotosensitizing AgentsGlutathione

Stichwörter der Autor:innen

S‐nitrosylationnitric oxide (NO)photodynamic therapyprogrammed therapytime‐sequential effect

Substanzen

Nitric OxidePhotosensitizing AgentsGlutathione

Autor:innen und Institutionen

  • Department of Pharmacy, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
  • Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
  • School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, China.
  • School of Biology and Engineering, and School of Basic Medical Sciences, Guizhou Medical University, Guiyang, Guizhou, 550000, China.
  • Department of Medical Imaging, First Hospital of Shanxi Medical University, Taiyuan, 030001, China.
  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics, Chinese Academy of Sciences, Beijing, 100049, China.

ORCID-Profile: Xiao Zhang

Förderung

  • National Natural Science Foundation of China
  • Southwest Hospital
  • Natural Science Foundation of Chongqing Municipality
  • Jinfeng Laboratory

Zitieren

APA

Wang, C., Zhu, J., Lin, L., Yu, J., Xu, H., Du, J., Gu, Z., Bian, X. W., Hu, J., Tian, G., & Zhang, X. (2025). Programmed Design of Nitric Oxide and Photodynamic Therapy Based on Orthogonal Upconversion Nanoparticles Improves Anti‐Tumor Efficacy via Protein S‐nitrosylation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502137

Vancouver

Wang C, Zhu J, Lin L, Yu J, Xu H, Du J, et al. Programmed Design of Nitric Oxide and Photodynamic Therapy Based on Orthogonal Upconversion Nanoparticles Improves Anti‐Tumor Efficacy via Protein S‐nitrosylation. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202502137

BibTeX
@article{Wang2025,
  author = {Wang, Chengyan and Zhu, Jiahui and Lin, Ling and Yu, Jie and Xu, Hao and Du, Jiangfeng and Gu, Zhanjun and Bian, Xiu-Wu and Hu, Jing and Tian, Gan and Zhang, Xiao},
  title = {Programmed Design of Nitric Oxide and Photodynamic Therapy Based on Orthogonal Upconversion Nanoparticles Improves Anti‐Tumor Efficacy via Protein S‐nitrosylation},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202502137}
}
Kostenlos starten →